17,785 Shares in Seer, Inc. (NASDAQ:SEER) Bought by AQR Capital Management LLC

AQR Capital Management LLC bought a new position in Seer, Inc. (NASDAQ:SEER) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 17,785 shares of the company’s stock, valued at approximately $30,000.

A number of other institutional investors also recently bought and sold shares of SEER. Vanguard Group Inc. raised its holdings in Seer by 1.0% during the first quarter. Vanguard Group Inc. now owns 2,636,577 shares of the company’s stock valued at $5,009,000 after acquiring an additional 25,944 shares during the period. Acadian Asset Management LLC raised its holdings in Seer by 35.5% during the second quarter. Acadian Asset Management LLC now owns 1,802,106 shares of the company’s stock valued at $3,024,000 after acquiring an additional 472,283 shares during the period. Kent Lake Capital LLC bought a new stake in Seer during the first quarter valued at about $1,425,000. Russell Investments Group Ltd. raised its holdings in Seer by 13.0% during the first quarter. Russell Investments Group Ltd. now owns 94,868 shares of the company’s stock valued at $180,000 after acquiring an additional 10,951 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in Seer during the second quarter valued at about $148,000. 75.20% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Morgan Stanley decreased their price target on Seer from $7.00 to $3.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 13th.

Seer Stock Down 0.5 %

NASDAQ:SEER opened at $1.93 on Friday. The stock has a market cap of $125.01 million, a PE ratio of -1.48 and a beta of 1.46. The business’s 50-day simple moving average is $1.77 and its two-hundred day simple moving average is $1.82. Seer, Inc. has a 52 week low of $1.46 and a 52 week high of $2.30.

Seer (NASDAQ:SEER) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.35) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.36) by $0.01. The firm had revenue of $3.07 million during the quarter, compared to analyst estimates of $3.33 million. Seer had a negative return on equity of 21.26% and a negative net margin of 559.21%. During the same quarter last year, the business posted ($0.37) earnings per share. Sell-side analysts anticipate that Seer, Inc. will post -1.27 earnings per share for the current fiscal year.

About Seer

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.